Page last updated: 2024-08-22

methional and quinazolines

methional has been researched along with quinazolines in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chantepie, J; Fournet, G; Giliberto, JP; Goré, J; Hiltbrand, E; Mehier, H; Morel, D; Paret, MJ; Quash, G; Reichert, U; Rochedix, ME	1

Other Studies

1 other study(ies) available for methional and quinazolines

Article	Year
Synergetic bitherapy in mice with xenografts of human prostate cancer using a methional mimic (METLICO) and an aldehyde dehydrogenase 3 inhibitor (MATE): systemic intraperitoneal (IP) and targeted intra-tumoral (IT) administration. Current medicinal chemistry, 2009, Volume: 16, Issue:10 Topics: Aldehyde Dehydrogenase; Aldehydes; Animals; Biomimetics; Combined Modality Therapy; Drug Delivery Systems; Enzyme Inhibitors; Female; Humans; Injections, Intralesional; Injections, Intraperitoneal; Male; Mice; Mice, Nude; Molecular Structure; Morpholines; Prostatic Neoplasms; Quinazolines; Tumor Burden	2009

Article

Year

Synergetic bitherapy in mice with xenografts of human prostate cancer using a methional mimic (METLICO) and an aldehyde dehydrogenase 3 inhibitor (MATE): systemic intraperitoneal (IP) and targeted intra-tumoral (IT) administration.

Current medicinal chemistry, 2009, Volume: 16, Issue:10

Topics: Aldehyde Dehydrogenase; Aldehydes; Animals; Biomimetics; Combined Modality Therapy; Drug Delivery Systems; Enzyme Inhibitors; Female; Humans; Injections, Intralesional; Injections, Intraperitoneal; Male; Mice; Mice, Nude; Molecular Structure; Morpholines; Prostatic Neoplasms; Quinazolines; Tumor Burden

2009